Dana-Farber/Brigham and Women's Cancer Center has a long history utilizing cellular therapies to treat blood cancers and blood disorders. Over more than 30 years, we have performed more than 9,200 hematopoietic stem cell transplants, the original form
of cellular therapy. We continue to offer patients the latest treatments, including CAR T-cell therapy, other genetically-modified T cells, and cancer vaccines.
The Connell and O'Reilly Cell Manipulation Core Facility (CMCF) is a key part of our cellular therapy program, processing almost 1,400 cellular products
each year, including cells for more than 600 adult and pediatric stem cell transplants. The CMCF supports more than 40 diverse active clinical research protocols, with a focus on translational research in stem cell transplantation and immune therapy
Stem Cell Transplant Resources
Cellular Therapies Resources